The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09I | Tumour detection | |
| 4 | V09IX | Other diagnostic radiopharmaceuticals for tumour detection | |
| 5 | V09IX05 | Fluorodopa (18F) |
| Active Ingredient | Description | |
|---|---|---|
| Fluorodopa ¹⁸F |
Fluorodopa F18 is a radioactive diagnostic agent used in PET imaging. In dopaminergic nerve terminals in the brain, fluorodopa (FDOPA) F18 is decarboxylated by amino acid decarboxylase to fluorodopamine (FDA) F18 and stored in presynaptic vesicles in the brain. The accumulation of F18 FDA in the striatum is visually detected in the PET scan. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOPACIS Solution for injection | Medicines Authority (MT) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
